tirzepatide synergy nash Shows Promise in Treating MASH: Key Findings from the SYNERGY- Study Consistent improvements in liver histology

Notably, liraglutide treatment significantly inhibited activated sodium-glucose co- transporter-2 (SGLT2) restored depressed insulin receptor substrate 1 (IRS1), and increased protein kinase G (PKG) levels

PMID 10725483

12 Recent studies provide a direct demonstration of actions of central GLP-1 and show projections from GLP-1containing neurons in the NTS to the nucleus accumbens core and of satiation induced by injections of GLP-1 into this region of the accumbens

Potential Side Effects and Reproductive Concerns Common GLP-1 side effects include nausea, constipation, and temporary appetite suppression, but none of these directly affect sperm production or erectile function

Breaking this cycle requires conscious intervention